Retail investors hold a significant 50% of Xeris Biopharma, giving them substantial influence over company decisions. Institutional investors own 45% of shares,
9988, known as the “Quantum Blockchain Protocol,” merges quantum computing with blockchain for enhanced efficiency and security. This protocol addresses scalability issues,
Yamanaka factors could revolutionize medicine by reducing aging-related illnesses through cellular rejuvenation. The potential decrease in pharmaceutical waste could lead to environmental